Breaking News Instant updates and real-time market news.

ICPT

Intercept

$97.33

-3.88 (-3.83%)

07:25
08/06/18
08/06
07:25
08/06/18
07:25

Intercept price target raised to $217 from $203 at Wedbush

Wedbush analyst Liana Moussatos raised her price target for Intercept to $217 from $203 after the company reported "strong" Q2 earnings. The analyst reiterates an Outperform rating on the shares.

  • 14

    Aug

  • 30

    Aug

  • 31

    Aug

ICPT Intercept
$97.33

-3.88 (-3.83%)

04/17/18
WEDB
04/17/18
NO CHANGE
Target $203
WEDB
Outperform
Intercept price target lowered to $203 from $256 at Wedbush
Wedbush analyst Liana Moussatos lowered her price target for Intercept to $203 from $256, citing reduced OCALIVA sales projections and diluted shares outstanding from financing. The analyst reiterates an Outperform rating on the shares.
06/28/18
RAJA
06/28/18
INITIATION
Target $122
RAJA
Strong Buy
Intercept initiated with a Strong Buy at Raymond James
Raymond James analyst Steven Seedhouse initiated Intercept with a Strong Buy and $122 price target.
08/03/18
LDLW
08/03/18
DOWNGRADE
LDLW
Hold
Intercept downgraded to Hold from Buy at Laidlaw
Laidlaw analyst Francois Brisebois downgraded Intercept to Hold from Buy with a $95 price target following the Q2 report citing valuation.
08/06/18
GSCO
08/06/18
UPGRADE
Target $157
GSCO
Buy
Intercept upgraded to Buy from Sell at Goldman Sachs
Goldman Sachs analyst Salveen Richter double upgraded Intercept Pharmaceuticals (ICPT) to Buy from Sell and raised his price target for the shares to $157 from $46. The stock closed Friday down 3.5%, or $3.57, to $97.26. The analyst says Ocaliva in fatty liver disease nonalcoholic steatohepatitis is the crux of Intercept's value proposition and that he's positive into the Phase 3 Regenerate interim readout in the first half of 2019. Richter this morning also downgraded Madrigal Pharmaceuticals (MDGL) to Neutral from Buy. He believes, however, that Madrigal's MGL-3196 is a "best-in-industry, next-generation" drug for nonalcoholic steatohepatitis. The analyst expects Intercept's Ocaliva will achieve one or both of the Phase 3 co-primary endpoints of NASH resolution and fibrosis improvement. He sees share upside of 60%-plus as the first half of 2019 catalyst approaches. Intercept should benefit from Ocaliva's global first-mover advantage in NASH, Richter tells investors in a research note. Goldman estimates peak global sales of NASH drugs to be $3.7B.

TODAY'S FREE FLY STORIES

RHHBY

Roche

$0.00

(0.00%)

05:16
03/19/19
03/19
05:16
03/19/19
05:16
Hot Stocks
Roche announces FDA approval of Tecentriq with chemotherapy for lung cancer »

Roche announced that the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Apr

  • 17

    Apr

  • 19

    Aug

  • 04

    Nov

05:10
03/19/19
03/19
05:10
03/19/19
05:10
General news
FX Action: USD-CAD has remained steady-but-heavy »

FX Action: USD-CAD has…

ALGN

Align Technology

$253.83

1.51 (0.60%)

05:09
03/19/19
03/19
05:09
03/19/19
05:09
Recommendations
Align Technology analyst commentary  »

Align Technology price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MGMB

MGM Holdings

$0.00

(0.00%)

, MGM.B

MGM Holdings

$0.00

(0.00%)

05:03
03/19/19
03/19
05:03
03/19/19
05:03
Recommendations
MGM Holdings, MGM Holdings analyst commentary at Imperial Capital »

MGM Holdings price target…

MGMB

MGM Holdings

$0.00

(0.00%)

MGM.B

MGM Holdings

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CWH

Camping World

$13.45

-0.07 (-0.52%)

04:55
03/19/19
03/19
04:55
03/19/19
04:55
Downgrade
Camping World rating change  »

Camping World downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

04:55
03/19/19
03/19
04:55
03/19/19
04:55
Conference/Events
UBS technology analyst to hold an analyst/industry conference call »

Technology Analyst Lowe…

AHT

Ashford Hospitality

$4.81

0.09 (1.91%)

04:55
03/19/19
03/19
04:55
03/19/19
04:55
Conference/Events
Ashford Hospitality management to meet with B. Riley FBR »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Mar

ANDE

Andersons

$34.32

-0.26 (-0.75%)

04:55
03/19/19
03/19
04:55
03/19/19
04:55
Conference/Events
Andersons management to meet with Buckingham »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Mar

  • 07

    May

04:55
03/19/19
03/19
04:55
03/19/19
04:55
General news
Breaking General news story  »

8-Week Bill Announcement…

CPST

Capstone Turbine

$0.93

0.0602 (6.91%)

, CEVA

Ceva

$27.85

-0.63 (-2.21%)

04:55
03/19/19
03/19
04:55
03/19/19
04:55
Conference/Events
Roth Capital to hold a conference »

31st Annual ROTH…

CPST

Capstone Turbine

$0.93

0.0602 (6.91%)

CEVA

Ceva

$27.85

-0.63 (-2.21%)

ORA

Ormat Technologies

$55.25

-0.12 (-0.22%)

ATEA

Astea

$0.00

(0.00%)

AKTS

Akoustis

$6.47

-0.02 (-0.31%)

ALRM

Alarm.com

$61.72

0.74 (1.21%)

VERI

Veritone

$6.49

0.23 (3.67%)

WAAS

AquaVenture

$19.78

-0.6 (-2.94%)

SRAX

Social Reality

$2.65

-0.06 (-2.21%)

MOBL

MobileIron

$5.03

0.03 (0.60%)

RUN

Sunrun

$14.85

0.09 (0.61%)

QTNA

Quantenna Communications

$21.07

-0.21 (-0.99%)

CWCO

Consolidated Water

$13.49

0.09 (0.67%)

EVER

EverQuote

$7.50

0.18 (2.46%)

PXLW

Pixelworks

$4.12

0.33 (8.71%)

BBSI

Barrett Business

$79.51

0.04 (0.05%)

FIVN

Five9

$54.86

0.43 (0.79%)

TMDI

Titan Medical

$3.29

(0.00%)

MNLO

Menlo Therapeutics

$7.98

0.15 (1.92%)

CRWS

Crown Crafts

$5.22

-0.025 (-0.48%)

ASUR

Asure Software

$6.22

-0.03 (-0.48%)

BOXL

Boxlight

$2.85

0.09 (3.26%)

CTEK

CynergisTek

$4.55

0.11 (2.48%)

EIDX

Eidos Therapeutics

$20.22

0.54 (2.74%)

IOTS

Adesto Technologies

$6.33

-0.1 (-1.56%)

SUMR

Summer Infant

$0.75

0.0024 (0.32%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Mar

  • 19

    Mar

  • 19

    Mar

  • 20

    Mar

  • 20

    Mar

  • 25

    Mar

  • 25

    Mar

  • 25

    Mar

  • 26

    Mar

  • 28

    Mar

  • 28

    Mar

  • 28

    Mar

  • 21

    May

  • 28

    May

  • 11

    Jun

NOAH

Noah Holdings

$46.87

0.5 (1.08%)

04:55
03/19/19
03/19
04:55
03/19/19
04:55
Conference/Events
Noah Holdings management to meet with JPMorgan »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Mar

  • 20

    Mar

  • 21

    Mar

  • 22

    Mar

ALDR

Alder Biopharmaceuticals

$13.72

0.21 (1.55%)

04:55
03/19/19
03/19
04:55
03/19/19
04:55
Conference/Events
Alder Biopharmaceuticals management to meet with SVB Leerink »

Meeting to be held in Los…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Mar

JMP

JMP Group

$3.86

-0.085 (-2.15%)

04:55
03/19/19
03/19
04:55
03/19/19
04:55
Conference/Events
JMP Group management to meet with Barrington »

Meeting to be held in San…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Mar

WCN

Waste Connections

$84.90

0.48 (0.57%)

04:55
03/19/19
03/19
04:55
03/19/19
04:55
Conference/Events
Waste Connections management to meet with Oppenheimer »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Mar

  • 20

    Mar

  • 17

    May

WIFI

Boingo Wireless

$21.14

-0.65 (-2.98%)

04:55
03/19/19
03/19
04:55
03/19/19
04:55
Conference/Events
Boingo Wireless management to meet with William Blair »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Mar

  • 20

    Mar

  • 28

    Mar

  • 29

    Mar

  • 28

    May

MKTX

MarketAxess

$237.77

4.27 (1.83%)

04:55
03/19/19
03/19
04:55
03/19/19
04:55
Conference/Events
MarketAxess management to meet with Buckingham »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Mar

MGA

Magna

$49.29

0.45 (0.92%)

04:55
03/19/19
03/19
04:55
03/19/19
04:55
Conference/Events
Magna management to meet with JPMorgan »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Mar

  • 21

    Mar

CYAD

Celyad

$21.35

(0.00%)

04:55
03/19/19
03/19
04:55
03/19/19
04:55
Conference/Events
Celyad management to meet with William Blair »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Mar

  • 20

    Mar

  • 04

    Apr

  • 09

    Apr

AEE

Ameren

$72.49

-0.55 (-0.75%)

04:55
03/19/19
03/19
04:55
03/19/19
04:55
Conference/Events
Ameren management to meet with Wolfe Research »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Mar

NGVT

Ingevity

$106.91

5.72 (5.65%)

04:55
03/19/19
03/19
04:55
03/19/19
04:55
Conference/Events
Ingevity management to meet with Loop Capital »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Mar

  • 25

    Apr

04:55
03/19/19
03/19
04:55
03/19/19
04:55
General news
Breaking General news story  »

4-Week Bill Announcement…

ITCI

Intra-Cellular

$12.84

-0.59 (-4.39%)

04:55
03/19/19
03/19
04:55
03/19/19
04:55
Conference/Events
Intra-Cellular participates in a conference call with JPMorgan »

JPMorgan Biotech Analyst…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Mar

  • 27

    Sep

PLYA

Playa Hotels & Resorts

$8.07

0.12 (1.51%)

04:55
03/19/19
03/19
04:55
03/19/19
04:55
Conference/Events
Playa Hotels & Resorts management to meet with SunTrust »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Mar

EXTN

Exterran

$18.30

0.4 (2.23%)

04:55
03/19/19
03/19
04:55
03/19/19
04:55
Conference/Events
Exterran management to meet with Piper Jaffray »

Meetings to be held In…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Mar

  • 20

    Mar

  • 25

    Apr

ITRM

Iterum Therapeutics

$5.63

0.16 (2.93%)

04:55
03/19/19
03/19
04:55
03/19/19
04:55
Conference/Events
Iterum Therapeutics management to meet with Needham »

Meeting to be held in Los…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Mar

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.